Overactive Bladder - Results from #1160

On the Site and Mechanism of Action of β3-Adrenoceptor Agonists in the Bladder. April 4, 2017

Evaluation of Overactive Bladder in Male Antidepressant Users: A Prospective Study April 4, 2017

Physiotherapy and behavior therapy for the treatment of overactive bladder syndrome: a prospective cohort study April 4, 2017

Urogynecological conditions associated with overactive bladder symptoms in women April 4, 2017

Does Systemic Disease Aggravate the Severity of Dry Mouth by Anticholinergics in Overactive Bladder Patients? March 21, 2017

Clinical and economic impact of mirabegron compared with antimuscarinics for the treatment of overactive bladder in Canada. March 21, 2017

Comparative study of the B-SAQ, OAB-V8 and OAB-V3 questionnaires as screening tools for overactive bladders in clinical practice. March 15, 2017

Pelvic Floor Muscle Training to Manage Overactive Bladder and Urinary Incontinence March 7, 2017

Translation and linguistic validation of the Persian version of the Bristol Female Lower Urinary Tract Symptoms instrument March 7, 2017

Persistence in the treatment of overactive bladder syndrome (OAB) with mirabegron in a multicenter clinical study March 7, 2017

Impact of Overactive Bladder Step Therapy Policies on Medication Utilization and Expenditures Among Treated Medicare Members March 7, 2017

Somatic, psychological, and sexual triggers for overactive bladder syndrome in women March 7, 2017

Indirect treatment comparison (ITC) of medical therapies for an overactive bladder March 7, 2017

Prevalence of Urinary Incontinence in Females Performing High-Impact Exercises March 7, 2017

The effect of extended release tolterodine used for overactive bladder treatment on female sexual function March 7, 2017

The long term predictive value of preoperative pressure flow studies in the resolution of overactive bladder after insertion of a retropubic midurethral sling February 28, 2017

Management of Overactive Bladder in the Face of High Grade Prolapse February 28, 2017

Cultural adaptation to Spanish (Spain) of the "Overactive Bladder - Family Impact Measure (OAB-FIM)" questionnaire February 28, 2017

Persistence and Adherence with Mirabegron versus Antimuscarinic Agents in Patients with Overactive Bladder: A Retrospective Observational Study in UK Clinical Practice February 28, 2017

Patient-Reported Outcomes with the B3-Adrenoceptor Agonist Mirabegron in Phase III Trial in Patients with Overactive Bladder - Commentary February 27, 2017

Page 59 of 122